CEL-SCI EBIT per Share
The EBIT per Share of CEL-SCI (CVM) as of Oct 10, 2026 is -3.09 USD. In the previous year, EBIT per Share was -12.02 USD — a change of -74.30% (higher).
Get this data via API
Financial Data API
EBIT per Share
-3.09USD
YoY
-74.30%
Last updated:
EBIT per Share of CEL-SCI is 2025 -3.09 USD. EBIT per Share of CEL-SCI was 2024 -12.02 USD. It decreases by -74.30% higher compared to the previous year.
The CEL-SCI EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-0.82 USD
Jan 1, 2022
-0.82 USD
Jan 1, 2023
-0.65 USD
Jan 1, 2024
-12.02 USD
Jan 1, 2025
-3.09 USD
Jan 1, 2026 (e)
-1.47 USD
Jan 1, 2027 (e)
-3.14 USD
Jan 1, 2028 (e)
9.85 USD
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 9.85USD | -413.60% |
| est | -3.14USD | +114.14% |
| est | -1.47USD | -52.50% |
| -3.09USD | -74.30% | |
| -12.02USD | +1,738.55% | |
| -0.65USD | -20.26% | |
| -0.82USD | +0.33% | |
| -0.82USD | -96.39% | |
| -22.62USD | +30.15% | |
| -17.38USD | +3,002.05% | |
| -0.56USD | -98.98% | |
| -55.01USD | -56.34% | |
| -126.00USD | -45.30% | |
| -230.33USD | -18.39% | |
| -282.23USD | -8.66% | |
| -308.99USD | -32.44% | |
| -457.37USD | -22.44% | |
| -589.69USD | -13.26% | |
| -679.86USD | +93.43% | |
| -351.48USD | -39.77% | |
| -583.58USD | -3.90% | |
| -607.29USD | +26.02% | |
| -481.91USD | — |
Access this data via the Eulerpool API
CEL-SCI Stock analysis
What does CEL-SCI do? CEL-SCI is one of the most popular companies on Eulerpool.
Frequently Asked Questions about CEL-SCI stock
EBIT per Share of CEL-SCI is -3.09 USD in 2025.
EBIT per Share of CEL-SCI changed from -12.02 USD to -3.09 USD, representing a -74.30% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share CEL-SCI since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — CEL-SCI
All Key Metrics — CEL-SCI
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth